Lacy Brian E
Professor of Medicine, Chief, Section of Gastroenterology & Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
J Fam Pract. 2017 Apr;66(4 Suppl):S40-S45.
Dietary and some other treatments for IBS are supported by a growing body of evidence, much of which comes from programs such as the Human Microbiome Project and Human Gut Microbiome Initiative, which were intended to identify and characterize microorganisms found in association with both healthy and diseased humans. These programs used state-of-the-art technology to characterize the human microbiome from multiple body sites. This evidence indicates that the gut microbiome plays an important role in IBS and some other gastrointestinal (GI) disorders.
越来越多的证据支持针对肠易激综合征的饮食及其他一些治疗方法,其中大部分证据来自人类微生物组计划和人类肠道微生物组计划等项目,这些项目旨在识别和描述与健康及患病人类相关的微生物。这些项目使用了最先进的技术来描述来自多个身体部位的人类微生物组。这一证据表明,肠道微生物组在肠易激综合征和其他一些胃肠道疾病中起着重要作用。